📰 Ilan Danieli News
Ilan Danieli News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ilan Danieli. Real-time updates on events, politics, business and more.
January 17, 2024
First order for IV-Cell placed by Major Japanese Laboratory...
January 17, 2024
NEW HAVEN, Conn., Jan. 17, 2024 -- Specialty cancer diagnostics company Precipio, Inc. announces it has entered into an agreement with a Japanese distributor for the sales and distribution of its...
January 2, 2024
02.01.2024 - Douglas Fisher, MD will step down as Director, and remain as a board observerNEW HAVEN, Conn., Jan. 02, 2024 (GLOBE NEWSWIRE) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is pleased to welcome Christina Valauri to its board ... Seite 1
September 25, 2023
NEW HAVEN, Conn., Sept. 25, 2023 -- Specialty cancer diagnostics company Precipio, Inc. announced that due to the increased pathology revenue, and the recent operational efficiencies, the...
September 13, 2023
13.09.2023 - Company continues to make strides towards profitabilityNEW HAVEN, Conn., Sept. 13, 2023 (GLOBE NEWSWIRE) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces its Pathology Division has in August exceeded the monthly ... Seite 1
August 19, 2023
Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript August 17, 2023 Precipio, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.1. Operator: Welcome to the Precipio Second Quarter 2023 Shareholder Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note that the conference is being recorded. Statements made during […]
May 22, 2023
Panel-Based Approach of Driver Mutation Detection Proves Crucial for Patient Care...
May 19, 2023
Operator: Welcome to the Precipio Q1 2023 Shareholder Update Conference Call. All participants will be in listen-only mode. Please note that the conference is being recorded.
May 4, 2023
04.05.2023 - Customer’s pathology services annual revenues expected to exceed $1.5MNEW HAVEN, Conn., May 04, 2023 (GLOBE NEWSWIRE) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces another agreement with a new pathology services ...
April 19, 2023
19.04.2023 - Q1-2023 product revenues approximately $0.76M exceeded the $0.66M combined revenue of Q3+Q4 2022NEW HAVEN, Conn., April 19, 2023 (GLOBE NEWSWIRE) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that Q1-2023 product ...